LL-37
An antimicrobial peptide studied for infection and immune defense.
Overview
LL-37 is the only cathelicidin-derived antimicrobial peptide (AMP) found in humans. It plays a critical role in the innate immune system, defending against bacteria, viruses, and fungi while also modulating inflammation and promoting wound healing.
Dosing
Injection
- Starting dose
- 250 mcg
- Common dose
- 250–500 mcg
- Frequency
- 1× daily
- Notes
- Highly bioactive — handle and dose with care.
Reported research/reference doses for educational purposes only. Always verify against primary literature and applicable regulations. Not medical advice.
How it works
LL-37 disrupts microbial membranes directly, killing a broad spectrum of pathogens. It also binds to immune cell receptors, promoting chemotaxis, regulating inflammation, and stimulating tissue repair and angiogenesis.
Common research uses
- Antimicrobial and anti-biofilm research
- Innate immune defense studies
- Wound healing and angiogenesis
- Inflammation modulation
Considerations
Research peptide. Highly bioactive, so dosing and handling require care. Most evidence is preclinical. Research use only.